|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/22 | (2006.01) |
| A61K 9/16 | (2006.01) | ||
| A61K 31/485 | (2006.01) |
| (11) | Number of the document | 3340968 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16838697.7 |
| Date of filing the European patent application | 2016-08-23 | |
| (97) | Date of publication of the European application | 2018-07-04 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-01 |
| (46) | Date of publication of the claims translation | 2022-09-12 |
| (86) | Number | PCT/IN2016/050280 |
| Date | 2016-08-23 |
| (87) | Number | WO 2017/033208 |
| Date | 2017-03-02 |
| (30) | Number | Date | Country code |
| 3223MU2015 | 2015-08-24 | IN |
| (72) |
SAXENA, Navin , IN
SAXENA, Kunal , IN
|
| (73) |
Rusan Pharma Limited ,
58-D, Government Industrial Estate Charkop
Kandivali (West), Mumbai 400067,
IN
|
| (74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
| (54) | Implantuojamos naltreksono tabletės |
| IMPLANTABLE NALTREXONE TABLETS |
| Payment date | Validity (years) | Amount | |
| 2023-08-04 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-08-23 |